26.06.2021 | Letter to Editor
SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist
Erschienen in: Journal of Clinical Immunology | Ausgabe 7/2021
Einloggen, um Zugang zu erhalten